Examine This Report on ADH-503
While ADH-503 did not target T cells specifically, our info counsel that it might increase anti-tumor T cell responses. We observed that ADH-503 bolstered each CD8+ and CD4+ effector T cell responses by expanding their quantities, activation, and proliferative status. Interestingly, we noticed increased proximity of CD8+ T cells to PDAC cells adher